fibrinogen has been researched along with Ischemia in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 53 (39.55) | 18.7374 |
| 1990's | 27 (20.15) | 18.2507 |
| 2000's | 28 (20.90) | 29.6817 |
| 2010's | 22 (16.42) | 24.3611 |
| 2020's | 4 (2.99) | 2.80 |
| Authors | Studies |
|---|---|
| Doelare, SAN; Ebben, HP; Ergin, K; Hoksbergen, AWJ; Jongkind, V; Lely, RJ; Oukrich, S; Wiersema, AM; Yeung, KK | 1 |
| Jeon, J; Lee, MS; Lim, J; Yang, HS | 1 |
| Halder, SK; Milner, R | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| de Borst, GJ; Huitema, ADR; Leenstra, B; van Ginkel, DJ; Verhoeven, BAN; Vonken, EJ | 1 |
| Guclu, H; Ozal, SA; Özgün, E; Özgün, GS; Pelitli Gurlu, V | 1 |
| Clark, RAF; Fenner, J; McClain, SA; Sasson, A; Singer, AJ; Tonnesen, MG | 1 |
| Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I | 1 |
| Araki, Y; Fujita, K; Hojo, Y; Ichikawa, S; Iwasaki, T; Kanai, H; Kasama, S; Kumakura, H; Minami, K; Nakashima, K; Sumino, H; Takayama, Y | 1 |
| Belaj, K; Brodmann, M; Eller, P; Froehlich, H; Gary, T; Gerger, A; Hackl, G; Hafner, F; Pichler, M; Pilger, E; Rief, P | 1 |
| Alvarez-Villaseñor, AS; Fuentes-Orozco, C; González-Ojeda, A; Leal-Cortés, C; Macías-Amezcua, MD; Orozco-Mosqueda, A; Portilla-de Buen, E; Vázquez-Camacho, G | 1 |
| Dirkmann, D; Görlinger, K; Hartmann, M; Kirchner, C; Paul, A; Saner, FH; Treckmann, JW | 1 |
| Horobeĭko, MB | 1 |
| Djikic, D; Kocev, N; Lip, GY; Marinkovic, JM; Polovina, MM; Potpara, TS | 1 |
| Işik, B; Karakukcu, M; Mutlu, FT; Ozdemir, MA; Patiroglu, T; Unal, E; Yilmaz, E | 1 |
| Pityk, AI | 1 |
| Gorokhova, VG; Koryakina, LB; Kuril'skaya, TE; Kuznetsova, EE; Pivovarov, YI | 1 |
| de Borst, GJ; Moll, FL; Roest, M; Teraa, M; Verhaar, MC; Wisman, PP | 1 |
| Baumgartner, I; Diehm, N; Dörffler-Melly, J; Husmann, M; Kalka, C; Silvestro, A | 1 |
| Bryan, D; Dippel, E; Jerin, M; Rauba, J; Shammas, G; Shammas, NW | 1 |
| Slowik, A; Szczudlik, A; Tracz, W; Undas, A; Wolkow, P | 1 |
| Guo, QX; Yu, J; Zhang, XM; Zhao, KQ | 1 |
| Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
| Bigalke, B; Borst, O; Daub, K; Fiesel, F; Gawaz, M; Gehring, EM; Koch, M; Kraemer, BF; Lang, F; Lindemann, S; Martinovic, I; Merz, T; Ninci, E; Schaller, M; Schmidt, C; Schoenberger, T; Schwanitz, L; Seizer, P; Stellos, K; Urban, B | 1 |
| Cheung, EY; de Lau, LM; de Maat, MP; den Hertog, HM; Dippel, DW; Koudstaal, PJ; Leebeek, FW; van den Herik, EG | 1 |
| Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ | 1 |
| Frikke-Schmidt, R; Grande, P; Haase, CL; Hornstrup, LS; Nordestgaard, BG; Sillesen, H; Tybjærg-Hansen, A | 1 |
| Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
| Filosso, PL; Ginardi, A; Mondini, G; Oliaro, A; Rosato, L; Sandri, A | 1 |
| Balmer, H; Baumgartner, I; Do, DD; Mahler, F; Triller, J | 1 |
| Bachoo, P; Brittenden, J; Cassar, K; Ford, I; Greaves, M | 1 |
| SAPIGNI, T | 1 |
| Kobayashi, S; Maesato, K; Moriya, H; Negishi, K; Ohtake, T | 1 |
| Bugra, Z; Demirel, S; Genchallac, H; Oflaz, H; Pusuroglu, H; Sever, MS; Yildiz, A | 1 |
| Checchia De Ambrosio, C; Cioffi Dagger, RP; Di Rienzo, F; Intiso, D; Lagioia, G; Simone, P; Tonali, P; Zarrelli, MM | 1 |
| Bottai, HM; Leiva, ML; Leroux, MB; Spengler, MI; Svetaz, MJ | 1 |
| Acs, G; Brath, E; Furka, I; Lesznyak, T; Miko, I; Nemeth, N; Szokoly, M | 1 |
| Biro, F; Kuegler, C; Michler, E; Rudofsky, G; Strubel, G | 1 |
| Beridze, N; Kipiani, K; Kipshidze, N; Kipshidze, NN; Moses, J; Roubin, G; Shehzad, MZ; Tsapenko, M | 1 |
| Kobayashi, S; Maesato, K; Moriya, H; Ohtake, T; Okamoto, K | 1 |
| Elisaf, MS; Goudevenos, J; Mikhailidis, DP; Milionis, HJ; Rizos, E; Seferiadis, K | 1 |
| Chung, JH; Jeon, O; Kim, BS; Ryu, SH | 1 |
| Diehm, C; Erdtracht, B; Gauss, V; Klingel, R; Mausfeld-Lafdhiya, P; Piazolo, A | 1 |
| Akaba, N; Ishimaru, S; Iwai, T; Shigematsu, H; Tsuchida, H; Umezu, S | 1 |
| Doillon, CJ; Griffith, M; Kapila, V; Li, F; Muzakare, L; Ruel, M; Suuronen, EJ | 1 |
| Blomstrand, C; Danielson, J; Jern, C; Jood, K; Ladenvall, C | 1 |
| Ashman, AA | 1 |
| Lote, K | 2 |
| Antoni, DH; Lüderitz, B | 1 |
| Dormandy, JA | 2 |
| Keltner, JL | 1 |
| Hársing, L; Losonczy, G | 1 |
| Berent, GA; Dormandy, JA; Yates, CJ | 1 |
| Graham, EM; Hunt, BJ; Jurd, KM; Palmer, HE; Sanders, MD; Stanford, MR; Zaman, AG | 1 |
| Lowe, GD; Pollock, JG; Rumley, A; Woodburn, KR | 1 |
| Chong, NH; Dodson, PM; Gibson, JM; Talks, SJ | 1 |
| Fujiki, K; Ohkusa, T; Sato, C; Tamura, Y | 1 |
| Fowkes, FG | 1 |
| Di Minno, G; Grandone, E; Margaglione, M | 1 |
| Jaakkola, P; Laakso, M; Manninen, HI; Matsi, PJ | 1 |
| Beck, GJ; Comerota, AJ; Curl, GR; Ghosh, S; Graor, RA; Rao, AK; Ricotta, JJ; Skibinski, CI; Sun, L; Throm, RC | 1 |
| Colburn, MD; Gelabert, HA; Hajjar, GE; Moore, WS; Nowara, H; Quiñones-Baldrich, WJ | 1 |
| Moore, JN; Prasse, KW; Topper, MJ; Welles, EG | 1 |
| Chaturvedi, S | 1 |
| Poredos, P; Zizek, B | 1 |
| Beck, SC; De Maio, A; Gingalewski, C; Theodorakis, NG; Yang, J | 1 |
| Love, J; Lowe, GD; Pollock, JG; Rumley, A; Woodburn, KR | 1 |
| Greenhalgh, RM; Hicks, RC; Higman, DJ; Moss, J; Powell, JT | 1 |
| Hakamada, K; Konn, M; Sasaki, M; Takahashi, K; Umehara, Y | 1 |
| Fowkes, FG; Lee, AJ; Leng, GC; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Cisar, LA; Kostis, JB; Philipp, CS; Saidi, P | 1 |
| Cheng, SW; Lau, H; Ting, AC; Wong, J | 1 |
| Balbarini, A; Barchielli, A; Berchiolli, R; Dell' Omo, G; Ferrari, M; Mariani, M; Melillo, E; Pedrinelli, R | 1 |
| Lowe, GD; Rumley, A | 1 |
| Fowkes, FG; Hau, CM; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Bergqvist, D; Holmberg, A; Sandhagen, B | 1 |
| Beall, D; Cornum, RL; Daniels, R; Gresham, V; Harris, R; Holcomb, J; Knight, RW; Macphee, M; Morey, AF; Pusateri, A | 1 |
| Aissa-Benhaddad, A; Baskürt, O; Bouchahda, C; Brun, JF; Granat, MC; Mercier, J; Sagnes, C | 1 |
| Inoue, A; Peer, G; Redl, H; Sakuragawa, N; Shiku, H; Taylor, FB; Wada, H; Yamamuro, M | 1 |
| Khodabandehlou, T; Le Devehat, C; Vimeux, M | 1 |
| Altman, R; Gonzalez, C; Rouvier, J; Scazziota, A | 1 |
| Mondek, P; Nosál, R; Pechán, I; Sefránek, V; Silvanová, E; Slysko, R; Tomka, J | 1 |
| Swedenborg, J; Thor, M; Yu, A | 1 |
| Buck, D; Eyster, ME; Gottleib, L; Graham, WP; Miller, SH; Saleem, A | 1 |
| Dean, RH; Yao, JS | 1 |
| Cox, JN; Nasah, BT | 1 |
| Claeys, H; Donati, MB; Vanhove, P; Verhaeghe, R; Vermylen, J | 1 |
| Hermann, G; Stock, W; Welter, H | 2 |
| Dormandy, J; Goyle, K; Postlethwaite, J | 1 |
| Fonkalsrud, EW; Sanchez, M; Webber, M; Zerubavel, R | 1 |
| Cherry, GW; Opie, LH | 1 |
| Rhodes, GR; Silver, D | 1 |
| Messner, H; Pannike, A; Siebert, H; Vontin, H | 1 |
| Abitbol, MM; Gallo, GR; Ober, WB; Pirani, CL | 1 |
| Barrie, WW; Schenk, WG | 1 |
| Lazúr, J; Takác, M; Tkác, I; Tkácová, R | 1 |
| Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C | 1 |
| Druid, H; Rammer, L | 2 |
| Greenhalgh, RM; Powell, JT | 1 |
| Hübner, C; Kohlschütter, A; Lehr, HA; Messmer, K; Nolte, D | 1 |
| Bird, AR; Bracher, M; Hickman, R; Jacobs, P; Pienaar, BH; Terblanche, J | 1 |
| Belgrad, D; Zwiener, U | 1 |
| Dain, R; Greenhalgh, RM; Kenchington, G; Marshall, CE; McCollum, CN; Powell, JT; Wiseman, S | 1 |
| Edwalds, G; Fishbein, MC; Kulber, D; Stancl, M | 1 |
| Carbonell, C; Cortés, J; Marugán, MI; Mendoza, A; Ortega, J; Ruiz, MA | 1 |
| Barrett, MC; Cream, JJ; Pardy, BJ; Prendiville, JS | 1 |
| Boks, AL; Bruinvels, J; de Groot, GH; Jeekel, H; Reuvers, CB; Schalm, SW; ten Kate, FW; Terpstra, OT | 1 |
| Frank, I; Hänsgen, K; Klare, M; Podhaisky, H; Preuss, EG; Sternitzky, R | 1 |
| Losonczy, G | 1 |
| Czekala, Z; Dosiak, J; Kokot, F; Kuska, J; Nowak, A | 1 |
| Hoie, J; Lyrdal, F | 1 |
| Lord, RS; McGarth, MA; Penny, R; Tracy, GD | 1 |
| Salaman, JR | 2 |
| Wardle, EN; Wright, NA | 1 |
| Ardlie, NG | 1 |
| Faivre, J; Favre-Gilly, J; Michel, D; Schott, B; Tommasi, M | 1 |
| Heene, DL; Höbel, W; Pfeiffer, H; Rompel, K | 1 |
| Davis, E; Rozov, H | 1 |
| Clarkson, AR; Davison, AM; MacDonald, MK | 1 |
| Pilgeram, LO | 1 |
| Brentijens, JR; Feltkamp-Vroom, T; Helder, AW; Vreeken, J | 1 |
| Antoine, B; Dorrington Ward, P; Neveu, T | 1 |
| Baddeley, RM; Slapak, M | 1 |
| Fleisher, R; Hague, R; Kolthammer, J; Shilkin, KB; Williams, R; Winch, J | 1 |
| Cordonnier, D; Couderc, P; Kolodie, L; Martin, H; Massot, C; Muller, JM; Schaerer, R | 1 |
| Beaumont, JL; Buxtorf, JC; Gorin, N; Jacotot, B | 1 |
| Karpinskaia, VM; Zaretskaia, IKh | 1 |
| Blaisdell, FW; Cafferata, HT; Robinson, AJ | 1 |
9 review(s) available for fibrinogen and Ischemia
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Effects of anaesthesia and surgery on the flow properties of blood.
Topics: Anesthesia; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemodilution; Hemoglobins; Humans; Ischemia; Male; Microcirculation; Surgical Procedures, Operative | 1984 |
Fibrinogen and peripheral arterial disease.
Topics: Adult; Aged; Arteriosclerosis; Female; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Risk Factors; Sex Factors; Smoking | 1995 |
Plasma predictors of ischemic complications of atherosclerosis: open issues.
Topics: Antibodies, Anticardiolipin; Arteriosclerosis; Fibrinogen; Humans; Ischemia; Leukocyte Count; Lipoprotein(a); Lupus Coagulation Inhibitor; Plasminogen Activator Inhibitor 1 | 1993 |
Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.
Topics: Animals; Arterial Occlusive Diseases; Biomarkers; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Thrombosis | 1999 |
[Hemorheological aspects of leuko-platelet activation in atheromatous diseases: clinical applications].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Blood Platelets; Blood Viscosity; Cytokines; Endothelium, Vascular; Feedback; Fibrinogen; Free Radicals; Hemorheology; Humans; Inflammation; Ischemia; Leg; Leukocytes; Nitric Oxide; Risk Factors; Thrombophilia; Thrombosis | 2000 |
Hemodynamic measurements in peripheral vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Electromagnetic Phenomena; Fibrinogen; Fingers; Hand; Hemodynamics; Humans; Ischemia; Middle Aged; Plethysmography, Impedance; Radionuclide Imaging; Rheology; Thrombophlebitis; Ultrasonography; Vascular Diseases | 1976 |
Microangiopathic haemolytianaemia.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anemia, Hemolytic; Blood Coagulation Disorders; Cerebrovascular Disorders; Dialysis; Factor V; Factor VIII; Fibrinogen; Heparin; Humans; Ischemia; Kidney; Purpura, Thrombocytopenic; Shwartzman Phenomenon; Splenectomy; Thrombocytopenia; Thrombosis | 1969 |
Mechanism of platelet aggregation and release: their possible role in vascular injury.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Coagulation; Blood Platelets; Blood Proteins; Blood Vessels; Collagen; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Glass; Graft Rejection; Hemostasis; Humans; Ischemia; Kidney Transplantation; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; Transplantation, Homologous | 1973 |
13 trial(s) available for fibrinogen and Ischemia
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Collagen; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Platelet Activation; Risk Factors; Thrombin | 2015 |
Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle; Arterial Occlusive Diseases; Brachial Artery; C-Reactive Protein; Female; Femoral Artery; Fibrinogen; Humans; Inflammation Mediators; Intermittent Claudication; Ischemia; Leukocyte Count; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prospective Studies; Regional Blood Flow; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation | 2008 |
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Topics: Aged; Analysis of Variance; Angioplasty; Arterial Occlusive Diseases; Aspirin; Batroxobin; China; Constriction, Pathologic; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Magnetic Resonance Angiography; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2011 |
Therapeutic angiogenesis for patients with limb ischemia by utilization of fibrin meshwork. Pilot randomized controlled study.
Topics: Adult; Deferoxamine; Drug Therapy, Combination; Feasibility Studies; Fibrin; Fibrinogen; Humans; Injections, Intramuscular; Ischemia; Male; Middle Aged; Neovascularization, Physiologic; Pilot Projects; Vascular Endothelial Growth Factors | 2003 |
Rheopheresis in patients with critical limb ischemia--results of an open label prospective pilot trial.
Topics: Aged; alpha-Macroglobulins; Blood Gas Monitoring, Transcutaneous; Cholesterol, LDL; Female; Fibrinogen; Humans; Immunoglobulin M; Ischemia; Lower Extremity; Male; Middle Aged; Pilot Projects; Plasmapheresis; Prospective Studies; Proteins; Regional Blood Flow; Skin; Treatment Outcome; Wound Healing | 2005 |
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Erythrocytes; Exercise Test; Exercise Tolerance; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Hypercholesterolemia; Intermittent Claudication; Ischemia; Japan; Lower Extremity; Male; Microcirculation; Middle Aged; Peripheral Vascular Diseases; Plasmapheresis; Plethysmography; Recovery of Function; Severity of Illness Index; Spectroscopy, Near-Infrared; Treatment Outcome; Triglycerides | 2006 |
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Critical Illness; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Ischemia; Leg; Male; Middle Aged; Prospective Studies; von Willebrand Factor | 1995 |
A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects.
Topics: Aged; Chronic Disease; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Infusions, Intra-Arterial; Intraoperative Care; Ischemia; Leg; Male; Middle Aged; Plasminogen; Postoperative Complications; Prospective Studies; Single-Blind Method; Urokinase-Type Plasminogen Activator | 1993 |
Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease.
Topics: Adult; Antioxidants; Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemodynamics; Humans; Hypolipidemic Agents; Ischemia; Leg; Male; Middle Aged; Niacin; Warfarin | 1998 |
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Thrombosis; Vascular Diseases | 1992 |
[The rheologic effects of ultraviolet irradiation of autologous blood with and without lymphocytes].
Topics: Adult; Aged; alpha-Macroglobulins; Blood; Blood Viscosity; Fibrinogen; Humans; Ischemia; Leg; Leukapheresis; Lymphocyte Depletion; Lymphocytes; Male; Middle Aged; Rheology; Ultraviolet Therapy | 1989 |
Influence of smoking and plasma factors on patency of femoropopliteal vein grafts.
Topics: Aged; Cholesterol; Female; Femoral Artery; Fibrinogen; Humans; Ischemia; Leg; Male; Middle Aged; Multicenter Studies as Topic; Popliteal Artery; Prospective Studies; Risk Factors; Saphenous Vein; Smoking; Vascular Patency | 1989 |
113 other study(ies) available for fibrinogen and Ischemia
| Article | Year |
|---|---|
Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Topics: Arterial Occlusive Diseases; Clinical Decision-Making; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Prospective Studies; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2023 |
Fibrinogen-based cell and spheroid sheets manipulating and delivery for mouse hindlimb ischemia.
Topics: Animals; Fibrinogen; Hindlimb; Ischemia; Membranes, Artificial; Mice; Neovascularization, Physiologic | 2023 |
A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord.
Topics: Animals; Antigens, Surface; Astrocytes; Central Nervous System; Disease Models, Animal; Endothelium; Female; Fibrinogen; Gray Matter; Hypoxia; Ischemia; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neuroglia; Organic Chemicals; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Spinal Cord; White Matter | 2019 |
Fibrinogen Degradation Speed as a Predictor of Major Bleeding Complications During Catheter Directed Thrombolysis in Patients with Acute Lower Limb Ischaemia.
Topics: Acute Disease; Biological Variation, Population; Catheters; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Lower Extremity; Peripheral Arterial Disease; Predictive Value of Tests; Proteolysis; Reference Values; Risk Assessment; Thrombolytic Therapy; Treatment Outcome | 2021 |
Increased Fibrinogen to Albumin Ratio in Ischemic Retinal Vein Occlusions.
Topics: Adult; Aged; Albumins; Case-Control Studies; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Retinal Vein Occlusion; ROC Curve | 2017 |
Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Burns; Disease Progression; Erythrocyte Aggregation; Fibrinogen; Humans; Inflammation; Ischemia; Microvessels; Necrosis; Peptides; Skin; Vasodilator Agents | 2018 |
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Risk Factors; Treatment Outcome | 2018 |
Differences in brain natriuretic peptide and other factors between Japanese peripheral arterial disease patients with critical limb ischemia and intermittent claudication.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography; Ankle Brachial Index; Asian People; Body Mass Index; Cholesterol; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Intermittent Claudication; Ischemia; Japan; Leg; Male; Middle Aged; Natriuretic Peptide, Brain; Peripheral Arterial Disease; Prevalence; Risk Factors; Sex Factors; Smoking | 2013 |
Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Topics: Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Extremities; Female; Fibrinogen; Humans; Ischemia; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Peripheral Arterial Disease; Platelet Count; Risk Assessment; Risk Factors | 2013 |
Fibrinogen and thrombin concentrations are critical for fibrin glue adherence in rat high-risk colon anastomoses.
Topics: Anastomosis, Surgical; Animals; Collagen; Colon; Female; Fibrin Tissue Adhesive; Fibrinogen; Hydroxyproline; Ischemia; Pressure; Rats, Sprague-Dawley; Reproducibility of Results; Risk Factors; Thrombin; Tissue Adhesives; Treatment Outcome; Wound Healing | 2014 |
Coagulation management with factor concentrates in liver transplantation: a single-center experience.
Topics: Adult; Algorithms; Blood Coagulation; Blood Coagulation Factors; Blood Component Transfusion; Female; Fibrinogen; Humans; Ischemia; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Thrombelastography; Thrombosis; Transfusion Reaction; Ultrasonography, Doppler | 2014 |
[Determination of efficacy of second application of Urokinase Medac in a diabetic foot syndrome].
Topics: Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Administration Schedule; Fibrinogen; Humans; Ischemia; Leg; Re-Epithelialization; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2014 |
The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Prognosis; Risk Factors; Stroke; Treatment Outcome; Troponin I; United States | 2014 |
A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations.
Topics: Afibrinogenemia; Amputation, Surgical; Anemia; Anticoagulants; Blood Coagulation Tests; Disease Progression; Enoxaparin; Female; Fibrinogen; Foot; Heparin; Humans; Ischemia; Necrosis; Recurrence; Toes; Young Adult | 2015 |
[Risk assessment of unfavorable outcome after revascularization the lower extremities in patients with critical ischemia of their tissues].
Topics: Aged; Biomarkers; C-Reactive Protein; Endovascular Procedures; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Ischemia; Leg; Male; Plastic Surgery Procedures; Postoperative Complications; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome | 2014 |
Role of Endogenous Factors in Response of Erythrocyte Membrane in Patients with Cardiovascular Diseases under Conditions of Ischemic Exposure.
Topics: Adsorption; Adult; Angina, Stable; Arm; Blood Viscosity; Brachial Artery; Constriction; Coronary Disease; Erythrocyte Membrane; Fibrinogen; Hemoglobins; Humans; Ischemia; Lipids; Male; Malondialdehyde; Middle Aged; Nucleotides; Plasminogen; Platelet Adhesiveness; von Willebrand Factor | 2015 |
Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Cohort Studies; Complement C5a; Coronary Artery Disease; Coronary Restenosis; Extremities; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Ischemia; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Registries; Regression Analysis; Risk Factors; Sex Factors | 2009 |
Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Topics: Acute Disease; Aged; Blood Coagulation Tests; Family; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Thrombosis; Ischemia; Male; Middle Aged; Permeability; Stroke; Thrombosis | 2010 |
[Analysis of relative factors of restenosis after artificially grafting bypasses on chronic ischemia of lower extremities].
Topics: Aged; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Chronic Disease; Diabetes Complications; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; Interleukin-6; Ischemia; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Transforming Growth Factor beta1 | 2009 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
PI3 kinase-dependent stimulation of platelet migration by stromal cell-derived factor 1 (SDF-1).
Topics: Animals; Blood Platelets; Blood Vessels; Cell Movement; Chemokine CXCL12; Chemotaxis; Collagen; Endothelium; Fibrinogen; GTP-Binding Proteins; Humans; Ischemia; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Phosphorylation; Porosity; Receptors, CXCR4; Wiskott-Aldrich Syndrome Protein | 2010 |
γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke.
Topics: Aged; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Ischemia; Male; Middle Aged; Odds Ratio; Prognosis; Prospective Studies; Regression Analysis; Risk Factors; Stroke; Treatment Outcome | 2011 |
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Heterozygote; Humans; Ischemia; Lipids; Lipoproteins; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Myocardial Infarction; Pseudoxanthoma Elasticum; Risk Factors; Vascular Diseases | 2011 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Efficacy of fleece-bound sealing system (TachoSil®) in delayed anterior tracheal lacerations secondary to ischemic tracheal necrosis after total thyroidectomy.
Topics: Adult; Drug Combinations; Fibrinogen; Humans; Ischemia; Lacerations; Male; Necrosis; Surgical Sponges; Thrombin; Thyroidectomy; Time Factors; Trachea | 2012 |
Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Chronic Disease; Female; Fibrinogen; Hemodynamics; Humans; Ischemia; Leg; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence | 2002 |
Platelet activation is increased in peripheral arterial disease.
Topics: Aged; Female; Fibrinogen; Flow Cytometry; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; Prospective Studies | 2003 |
[NAI-131, SERUM ALBUMIN-I-131 AND FIBRINOGEN-I-131 AS TRACERS OF EXCHANGES BETWEEN CIRCULATING FLUIDS AND TISSUES DURING ISCHEMIA].
Topics: Fibrinogen; Iodine Isotopes; Ischemia; Liver; Radioisotopes; Radiometry; Rats; Research; Serum Albumin; Serum Albumin, Radio-Iodinated | 1963 |
LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Component Removal; Extremities; Female; Fibrinogen; Humans; Insulin-Like Growth Factor I; Ischemia; Lipoproteins, LDL; Male; Middle Aged; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2003 |
Endothelial function is more impaired in hemodialysis patients than renal transplant recipients.
Topics: Adult; Brachial Artery; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Forearm; Humans; Ischemia; Kidney Transplantation; Male; Regional Blood Flow; Renal Dialysis; Ultrasonography; Vasodilation | 2003 |
Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Central Nervous System; Electrocardiography; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Ischemia; Leukocytes; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Neutrophils; Stroke; Time Factors; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2004 |
Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.
Topics: Adult; Blood Physiological Phenomena; Blood Proteins; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Humans; Immunoglobulins; Ischemia; Logistic Models; Microcirculation; Microscopic Angioscopy; Raynaud Disease; Scleroderma, Systemic; Skin | 2004 |
Systemic and regional hemorheological consequences of warm and cold hind limb ischemia-reperfusion in a canine model.
Topics: Animals; Blood Viscosity; Body Temperature; Cold Temperature; Dogs; Erythrocyte Deformability; Erythrocyte Indices; Fibrinogen; Hematocrit; Hemorheology; Hindlimb; Ischemia; Models, Animal; Reperfusion Injury | 2004 |
Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Treatment Outcome | 2004 |
LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; C-Reactive Protein; Chemokine CCL2; Female; Fibrinogen; Hemofiltration; Humans; Inflammation; Ischemia; Lipoproteins, LDL; Male; Middle Aged; Peripheral Vascular Diseases | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Ischemia; Lipoprotein(a); Lipoproteins, HDL; Logistic Models; Male; Metabolic Syndrome; Obesity; Odds Ratio; Regression Analysis; Risk Factors; Stroke; Triglycerides; Uric Acid | 2005 |
Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.
Topics: Angiogenesis Inhibitors; Animals; Anticoagulants; Drug Delivery Systems; Drug Implants; Female; Fibrin; Fibrinogen; Fibroblast Growth Factor 2; Gels; Hemostatics; Heparin; Humans; Ischemia; Kinetics; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Thrombin | 2005 |
Promotion of angiogenesis in tissue engineering: developing multicellular matrices with multiple capacities.
Topics: Acrylamides; Acrylates; Animals; Coculture Techniques; Collagen; Cornea; Endothelial Cells; Extracellular Matrix; Fibrinogen; Hindlimb; Humans; Ischemia; Neovascularization, Physiologic; Polymers; Rats; Rats, Nude; Sclera; Stem Cell Transplantation; Stem Cells; Thrombin; Tissue Engineering | 2006 |
Fibrinogen gene variation and ischemic stroke.
Topics: Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Haplotypes; Humans; Ischemia; Linkage Disequilibrium; Male; Models, Genetic; Multigene Family; Odds Ratio; Polymorphism, Single Nucleotide; Stroke | 2008 |
[On changes in the level of fibrinogen in cerebral disorders].
Topics: Adult; Aged; Cerebral Hemorrhage; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged | 1966 |
Temporary ischaemia induced by degradable starch microspheres. Possible thrombogenic effects in vivo and in vitro.
Topics: Animals; Cats; Factor VIII; Fibrinogen; Intestine, Small; Ischemia; Male; Mesenteric Arteries; Microspheres; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Starch; Thrombosis | 1981 |
[Highly painful acral formation of necroses at a young age].
Topics: Adult; Angiography; Diagnosis, Differential; Fibrinogen; Fingers; Humans; Ischemia; Male; Necrosis; Thromboangiitis Obliterans | 1983 |
Hypoxic radioprotection by temporary intestinal ischemia: degradable starch microsphere embolization in the cat.
Topics: Animals; Blood Flow Velocity; Cats; Embolization, Therapeutic; Factor VIII; Female; Fibrinogen; Intestine, Small; Ischemia; Male; Mesenteric Vascular Occlusion; Microspheres; Oxygen; Platelet Count; Radiation Protection; Radiation Tolerance; Starch; Thrombosis | 1981 |
Giant-cell arteritis. Signs and symptoms.
Topics: Aged; Anemia; Blood Sedimentation; Eye Diseases; Female; Fibrinogen; Giant Cell Arteritis; Humans; Ischemia; Liver Function Tests; Oculomotor Muscles; Optic Nerve Diseases; Steroids | 1982 |
Simultaneous activation of coagulation and fibrinolysis after severe renal ischemia in rats.
Topics: Animals; Blood Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemoglobins; Ischemia; Kidney; Male; Nephrectomy; Platelet Count; Rats; Rats, Inbred Strains; Thrombin Time | 1982 |
Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects.
Topics: Adenosine Triphosphate; Blood Viscosity; Cerebral Infarction; Erythrocytes; Fibrinogen; Hematocrit; Hemodilution; Humans; Ischemia; Plasma Exchange; Risk | 1981 |
Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
Topics: Ancrod; Aspirin; Blood Viscosity; Chronic Disease; Erythrocyte Count; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Lipid Metabolism; Myocardial Infarction; Plasma Exchange; Rheology; Vascular Diseases; Vasodilator Agents | 1981 |
Thrombophilic factors in ischaemic and non-ischaemic idiopathic retinal vasculitis.
Topics: Adult; Blood Coagulation Factors; Female; Fibrinogen; Humans; Ischemia; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Protein C; Protein S; Retinal Diseases; Retinal Vessels; Smoking; von Willebrand Factor | 1995 |
Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Odds Ratio; Optic Nerve; Optic Nerve Diseases; Risk Factors; Smoking; Triglycerides | 1995 |
Evaluation of the effects of esophageal varicosclerosants on local vascular occlusion and systemic blood coagulation.
Topics: Animals; Arteries; Blood Coagulation; Ear, External; Female; Fibrinogen; Ischemia; Kidney; Liver; Lung; Necrosis; Platelet Count; Prothrombin Time; Rabbits; Sclerosing Solutions; Sclerotherapy; Spleen; Thrombosis; Veins | 1995 |
Impact of risk factors on limb salvage after angioplasty in chronic critical lower limb ischemia. A prospective trial.
Topics: Adult; Aged; Angioplasty, Balloon; Cholesterol, HDL; Chronic Disease; Female; Fibrinogen; Humans; Ischemia; Leg; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome | 1994 |
The effect of hypofibrinogenemia and fibrinolysis on skeletal muscle function after ischemia and reperfusion.
Topics: Afibrinogenemia; Ancrod; Animals; Fibrinogen; Fibrinolysis; Ischemia; Isometric Contraction; Male; Muscles; Plasminogen; Rabbits; Reperfusion; Time Factors; Urokinase-Type Plasminogen Activator | 1994 |
Analysis of hemostasis in horses with colic.
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Colic; Diagnosis, Differential; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Horse Diseases; Horses; Intestinal Obstruction; Intestine, Large; Intestine, Small; Ischemia; Partial Thromboplastin Time; Plasminogen; Prognosis; Protein C; Prothrombin Time; Retrospective Studies; Treatment Outcome | 1993 |
Fulminant cerebral infarctions with membranous nephropathy.
Topics: Adult; Cerebral Angiography; Cerebral Arteries; Cerebral Infarction; Female; Fibrinogen; Glomerulonephritis, Membranous; Humans; Ischemia; Protein S; Thrombosis | 1993 |
Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
Topics: Aged; Aged, 80 and over; alpha-Macroglobulins; Arteriosclerosis; Blood Glucose; Blood Viscosity; Cholesterol; Disease Progression; Female; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Plasma; Prognosis; Risk Factors | 1996 |
Distinct expression of heat shock and acute phase genes during regional hepatic ischemia-reperfusion.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Fibrinogen; Gene Expression; Heat-Shock Proteins; Heat-Shock Response; HSP72 Heat-Shock Proteins; Ischemia; Liver; Liver Circulation; Male; Metallothionein; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Sprague-Dawley; Reperfusion; RNA, Messenger | 1996 |
Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Topics: Age Factors; Aged; Angiography; Arterial Occlusive Diseases; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Reference Values; Rheology | 1995 |
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Blood Vessel Prosthesis; Bradykinin; Calcimycin; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Fibrinogen; Humans; In Vitro Techniques; Indomethacin; Ischemia; Leg; Male; Microscopy, Electron; Middle Aged; NG-Nitroarginine Methyl Ester; Postoperative Complications; Saphenous Vein; Time Factors; Vascular Diseases; Vascular Surgical Procedures; Vasodilation | 1997 |
Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver.
Topics: Animals; Antibodies, Monoclonal; Antithrombin III; Choline; Diet; Fatty Liver; Fibrinogen; Hot Temperature; Intercellular Adhesion Molecule-1; Ischemia; Liver; Male; Microcirculation; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors; Triglycerides | 1997 |
Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication.
Topics: Blood Viscosity; Disease Progression; Female; Fibrinogen; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Prognosis; Prospective Studies; Regional Blood Flow; Smoking | 1998 |
Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; China; Demography; Diabetes Mellitus; Female; Femoral Artery; Fibrinogen; Hong Kong; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipoproteinemias; Hypertension; Hypertriglyceridemia; Ischemia; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking | 1999 |
Fibrinogen and mortality in chronic critical limb ischaemia.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinogen; Humans; Ischemia; Italy; Leg; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis | 1999 |
Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Topics: Aged; Antifibrinolytic Agents; Antigens; Biomarkers; Blood Coagulation Factors; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tissue Plasminogen Activator; Urban Population; von Willebrand Factor | 2000 |
Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction.
Topics: Aged; Aged, 80 and over; Blood Viscosity; Case-Control Studies; Diabetes Mellitus; Elbow; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocyte Volume; Female; Femoral Vein; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Plasma; Renal Insufficiency; Veins | 2000 |
Does the absorbable fibrin adhesive bandage facilitate partial nephrectomy?
Topics: Absorbable Implants; Animals; Bandages; Blood Coagulation; Blood Loss, Surgical; Cellulose, Oxidized; Female; Fibrin Tissue Adhesive; Fibrinogen; Hemostatics; Ischemia; Kidney; Kidney Tubules, Collecting; Ligation; Nephrectomy; Placebos; Polyglactin 910; Surgical Mesh; Suture Techniques; Swine; Thrombin; Time Factors; Tissue Adhesives; Tomography, X-Ray Computed; Wound Healing | 2000 |
Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non
Topics: alpha-2-Antiplasmin; Animals; Antifibrinolytic Agents; Antigens; Antithrombin III; Biomarkers; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Endothelium, Vascular; Escherichia coli Infections; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemostasis; Ischemia; Leukocyte Count; Leukocyte Elastase; Male; Models, Animal; Neutrophils; Papio; Peptide Hydrolases; Platelet Count; Predictive Value of Tests; Reperfusion; Sepsis; Thrombomodulin | 2001 |
Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
Topics: Adult; Aged; Arteries; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hypoxia; Ischemia; Leg; Male; Middle Aged; Serum Albumin | 2001 |
No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; C-Reactive Protein; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Chronic Disease; Coronary Artery Disease; Female; Fibrinogen; Heart Valve Prosthesis; Humans; Infant; Inflammation; Ischemia; Male; Middle Aged; Statistics, Nonparametric | 2002 |
[Regional biochemical and hematologic changes in patients after revascularization of the lower extremities in ischemia of the extremities].
Topics: Antioxidants; Blood Cell Count; Female; Fibrinogen; Humans; Ischemia; Lactic Acid; Leg; Leukocyte Elastase; Male; Malondialdehyde; Middle Aged; Vascular Surgical Procedures | 2002 |
Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia.
Topics: Aged; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Ischemia; Lower Extremity; Male; Thrombophilia | 2002 |
Intravascular coagulation and fibrinolysis within primate extremities during tourniquet ischemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Extremities; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Haplorhini; Heparin; Ischemia; Tourniquets | 1979 |
Vascular lesions in testes associated with male infertility in Cameroon. Possible relationship to parasitic disease.
Topics: Adult; Antigen-Antibody Complex; Atrophy; Biopsy; Blood Vessels; Complement System Proteins; Fibrinogen; Humans; Immunoglobulin M; Infertility, Male; Ischemia; Male; Middle Aged; Oligospermia; Parasitic Diseases; Testis | 1978 |
Action of brinase on human fibrinogen and plasminogen.
Topics: Antigens; Brinolase; Fibrinogen; Fibrinolysin; Filtration; Humans; Ischemia; Leg; Peptide Hydrolases; Plasminogen; Sepharose | 1979 |
[The protein distribution in the postischemic edema of dogs in reference to pathogenesis (author's transl)].
Topics: Animals; Blood Proteins; Cell Membrane Permeability; Dogs; Edema; Exudates and Transudates; Fibrinogen; Hemodynamics; Hindlimb; Humans; Hydrogen-Ion Concentration; Hyperemia; Immunoelectrophoresis; Ischemia; Lymph; Osmotic Pressure; Proteins; Rabbits; Regional Blood Flow | 1975 |
Haemorheological therapy.
Topics: Animals; Blood Viscosity; Clofibrate; Fibrin; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Leg; Rabbits | 1977 |
Localization of injury in arteries by I-125 fibrinogen uptake.
Topics: Animals; Dogs; Endothelium; Femoral Artery; Fibrinogen; Glucose; Iodine Radioisotopes; Ischemia; Microscopy, Electron, Scanning; Perfusion; Thrombosis; Wound Healing | 1978 |
Decreased myocardial fibrinolytic activity following temporary ischaemia and reperfusion.
Topics: Animals; Coronary Circulation; Endocardium; Fibrin; Fibrinogen; Fibrinolysis; Haplorhini; Ischemia; Myocardial Infarction; Papio | 1975 |
Periepicardial fibrinolytic activity: relation to cardiac bleeding.
Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Tests; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cats; Electric Stimulation; Fibrin; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Injections, Intravenous; Ischemia; Pericardium; Postoperative Complications; Streptokinase; Ventricular Fibrillation | 1975 |
[Studies after tourniquet ischemia. I. Behavior of thrombocyte count and fibrinogen after 3 hours tourniquet ischemia in the extremities in splenectomized and non-splenectomized dogs].
Topics: Animals; Blood Platelets; Dogs; Fibrinogen; Ischemia; Splenectomy; Tourniquets | 1975 |
Production of experimental toxemia in the pregnant rabbit.
Topics: Animals; Aorta, Abdominal; Blood Pressure Determination; Constriction; Disease Models, Animal; Female; Fibrinogen; Hypertension; Ischemia; Kidney Glomerulus; Liver; Placenta; Pre-Eclampsia; Pregnancy; Proteinuria; Rabbits | 1976 |
Improvement in blood flow through a critical arterial stenosis by defibrination with ancrod.
Topics: Ancrod; Animals; Blood Pressure; Blood Viscosity; Cardiac Output; Dogs; Endopeptidases; Femoral Artery; Fibrinogen; Hindlimb; Ischemia; Ligation; Regional Blood Flow | 1976 |
Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
Topics: Arteriosclerosis Obliterans; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemoglobinometry; Humans; Ischemia; Leg; Leukocyte Count; Male; Middle Aged; Platelet Count | 1992 |
Protective effect on postischemic renal edema by anticoagulation.
Topics: Animals; Blood Pressure; Edema; Female; Fibrinogen; Heparin; Ischemia; Kidney; Kidney Diseases; Rats; Rats, Inbred Strains; Renal Artery; Renal Circulation; Serum Albumin; Warfarin | 1992 |
Smoking and factors influencing the outcome of arterial reconstruction.
Topics: Aged; Blood Vessel Prosthesis; Carboxyhemoglobin; Cholesterol; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; Ischemia; Leg; Male; Middle Aged; Patient Compliance; Postoperative Complications; Recurrence; Reoperation; Risk Factors; Smoking; Thiocyanates; Veins | 1992 |
Dietary fish oil blocks the microcirculatory manifestations of ischemia-reperfusion injury in striated muscle in hamsters.
Topics: Animals; Blood Viscosity; Cricetinae; Dietary Fats; Fibrinogen; Fish Oils; Hemodynamics; Ischemia; Leukotriene B4; Mesocricetus; Microcirculation; Muscles; Partial Thromboplastin Time; Reperfusion Injury | 1991 |
Heparin as the cause of coagulopathy which may complicate grafting of the liver.
Topics: Animals; Blood Coagulation Disorders; Evaluation Studies as Topic; Fibrinogen; Fibrinolysis; Heparin; Hepatectomy; Hypothermia, Induced; Ischemia; Liver; Liver Transplantation; Platelet Count; Swine; Time Factors; Whole Blood Coagulation Time | 1991 |
Reduction of renal edema by heparin in postischemic renal damage.
Topics: Animals; Edema; Female; Fibrinogen; Heparin; Ischemia; Kidney; Kidney Diseases; Ligation; Organ Size; Rats; Rats, Inbred Strains; Renal Artery; Renal Circulation; Reperfusion; Serum Albumin | 1989 |
Distribution of fibrinogen and albumin in normal, ischaemic, and necrotic myocardium during the evolution of myocardial infarction: an immunohistochemical study.
Topics: Albumins; Animals; Coronary Vessels; Dogs; Fibrinogen; Immunologic Techniques; Ischemia; Myocardial Infarction; Myocardium; Necrosis | 1986 |
[Early changes in coagulation factors after temporary hepatic ischemia in the dog].
Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Dogs; Female; Fibrinogen; Ischemia; Liver; Male; Time Factors | 1986 |
Cryofibrinogenaemia and acute gangrene in systemic sclerosis.
Topics: Acute Disease; Blood Coagulation Disorders; Cold Temperature; Cryoglobulins; Fibrinogen; Fibrinogens, Abnormal; Gangrene; Humans; Ischemia; Male; Middle Aged; Scleroderma, Systemic | 1986 |
A reproducible model of acute hepatic failure by transient ischemia in the pig.
Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Electrophysiology; Fibrinogen; Guinea Pigs; Hemodynamics; Ischemia; Liver; Liver Diseases; Necrosis; Platelet Count; Portacaval Shunt, Surgical | 1987 |
[Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Ischemia; Leg; Male; Microcirculation; Middle Aged; Rheology | 1986 |
Early postischaemic renal fibrin deposition and reduction of glomerular filtration rate in the rat: effect of the defibrinating agent Arwin.
Topics: Ancrod; Animals; Fibrin; Fibrinogen; Fibrinolysis; Glomerular Filtration Rate; Ischemia; Kidney; Ligation; Male; Rats; Renal Artery; Thrombin Time | 1985 |
Fibrinolytic and renin activity in renal vein blood of patients with renovascular hypertension.
Topics: Catheterization; Fibrinogen; Fibrinolysin; Fibrinolysis; Hepatic Veins; Humans; Hypertension, Renal; Ischemia; Pheochromocytoma; Plasminogen; Posture; Renal Veins; Renin; Urography; Vanilmandelic Acid | 1969 |
[Immunoelectrophoretic study of protein distribution in the postischemic edema of dogs as compared to serum- and lymph-proteins (author's transl)].
Topics: Animals; Antibody Formation; Blood Proteins; Cell Membrane Permeability; Chemical Precipitation; Dogs; Edema; Fibrinogen; Forelimb; Hindlimb; Immune Sera; Immunoelectrophoresis; Immunoglobulin A; Immunoglobulin G; Ischemia; Lymph; Proteins; Rabbits | 1974 |
Some consequences of thrombin-induced ischemia and adrenalin infusions in the dog.
Topics: Animals; Aorta; Creatinine; Depression, Chemical; Disseminated Intravascular Coagulation; Dogs; Epinephrine; Female; Fibrinogen; Infusions, Parenteral; Ischemia; Kidney; Male; Methods; Muscle Contraction; Muscle, Smooth; Regional Blood Flow; Renal Artery; Stimulation, Chemical; Thrombin; Time Factors | 1974 |
Peripheral ischaemia caused by blood hyperviscosity.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Platelet Disorders; Blood Protein Disorders; Blood Sedimentation; Blood Viscosity; Cryoglobulins; Diabetes Complications; Fibrinogen; Fingers; Gangrene; Hematocrit; Hematologic Diseases; Humans; Ischemia; Male; Middle Aged; Polycythemia; Toes | 1973 |
A study of renal allograft rejection in the rat using 125I-fibrinogen.
Topics: Animals; Fibrinogen; Graft Rejection; Iodine Radioisotopes; Ischemia; Kidney; Kidney Transplantation; Rats; Renal Veins; Thrombophlebitis; Transplantation Immunology; Transplantation, Homologous; Ureteral Obstruction | 1972 |
Intravascular coagulation and glycerin hemoglobinuric acute renal failure.
Topics: Acute Kidney Injury; Aminocaproates; Animals; Autoradiography; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Glycerol; Half-Life; Hemoglobins; Hemoglobinuria; Iodine Isotopes; Ischemia; Kidney; Kidney Cortex Necrosis; Kidney Glomerulus; Kidney Tubules; Rabbits; Rats; Serum Albumin, Radio-Iodinated; Sympathectomy | 1973 |
A technique for detecting rejection episodes in human transplant recipients using radioactive fibrinogen.
Topics: Acute Kidney Injury; Biopsy; Creatinine; Fibrinogen; Graft Rejection; Heart; Humans; Immunosuppression Therapy; Iodine Radioisotopes; Ischemia; Kidney; Kidney Transplantation; Liver; Radionuclide Imaging; Time Factors; Transplantation, Homologous; Urea | 1972 |
[Ovarian cancer with diffuse vascular thrombosis. Endocardial, arterial and venous involvement. Disseminated intravascular coagulation with cryofibrinogen].
Topics: Cerebrovascular Disorders; Cold Temperature; Cystadenocarcinoma; Diplopia; Disseminated Intravascular Coagulation; Edema; Encephalomalacia; Endocarditis; Female; Fibrinogen; Foot Diseases; Gangrene; Hemiplegia; Heparin; Humans; Ischemia; Middle Aged; Ovarian Neoplasms; Thrombophlebitis; Thrombosis; Vena Cava, Superior | 1972 |
[Changes of coagulation after acute apoplectic strokes (author's transl)].
Topics: Acute Disease; Blood Coagulation Disorders; Blood Coagulation Tests; Cerebral Hemorrhage; Cerebrovascular Disorders; Fibrinogen; Humans; Ischemia; Prothrombin Time; Subarachnoid Hemorrhage; Thrombelastography; Time Factors | 1973 |
The effects of xanthinol nicotinate on the small blood vessels.
Topics: Amino Alcohols; Arteriosclerosis; Blood Viscosity; Conjunctiva; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hypertension; Ischemia; Male; Microcirculation; Middle Aged; Nicotinic Acids; Theophylline; Vascular Diseases; Vasodilator Agents | 1973 |
The role of coagulation in renal disease.
Topics: Acute Kidney Injury; Basement Membrane; Blood Coagulation Disorders; Diabetic Nephropathies; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Glomerulonephritis; Hemagglutination Tests; Hemolytic-Uremic Syndrome; Humans; Ischemia; Kidney; Kidney Diseases; Male; Middle Aged; Pre-Eclampsia; Pregnancy; Thrombosis; Urokinase-Type Plasminogen Activator | 1973 |
Abnormalities in clotting and thrombolysis as a risk factor for stroke.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Brain; Cerebrovascular Disorders; Cholesterol; Fibrin; Fibrinogen; Fibrinolysis; Humans; Ischemia; Plasminogen; Triglycerides | 1974 |
Pyelonephritis-like lesions as a late effect of diffuse intravascular coagulation.
Topics: Animals; Blood Coagulation Disorders; Creatinine; Factor V; Fibrinogen; Fluorescent Antibody Technique; Infusions, Parenteral; Ischemia; Kidney; Kidney Cortex Necrosis; Kidney Diseases; Kidney Glomerulus; Microscopy, Electron; Rabbits; Thrombin | 1968 |
[Fibrinuria in human renal transplantation].
Topics: Animals; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Glomerular Filtration Rate; Histocompatibility; Humans; Immune Sera; Immunoassay; Immunoelectrophoresis; Ischemia; Kidney; Kidney Transplantation; Macromolecular Substances; Prednisone; Proteinuria; Rabbits; Time Factors; Transplantation Immunology; Transplantation, Homologous | 1969 |
Preservation of the primate liver by simple cooling and orthoptic autotransplantation for 2 and one-half-6 hours.
Topics: Animals; Blood Platelets; Cold Temperature; Fibrinogen; Haplorhini; Hematocrit; Ischemia; Liver; Liver Function Tests; Liver Transplantation; Time Factors; Tissue Preservation; Transplantation, Autologous | 1970 |
Haemorrhage as a complication of extracorporeal pig liver perfusion: studies on mechanism and prevention.
Topics: Adolescent; Adult; Ammonia; Animals; Bile; Bilirubin; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Hemorrhage; Humans; Iodine Radioisotopes; Ischemia; Liver Circulation; Liver Diseases; Male; Perfusion; Sulfobromophthalein; Swine | 1972 |
[Moschcowitz's disease: consumption coagulopathy?].
Topics: Adult; Anemia, Hemolytic; Blood Coagulation Disorders; Cerebrovascular Disorders; Factor V; Factor VII; Factor X; Fever; Fibrinogen; Hemostasis; Heparin; Humans; Ischemia; Kidney Failure, Chronic; Male; Neurologic Manifestations; Prothrombin Time; Purpura, Thrombotic Thrombocytopenic; Thrombin; Thrombosis | 1969 |
[Arterial ischemic syndrome associated with plasma cryoprecipitation and cutaneous porphyria in adults].
Topics: Adenine Nucleotides; Adult; Antigen-Antibody Reactions; Autoantibodies; Blood Proteins; Chemical Precipitation; Cold Temperature; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Immunoglobulin G; Immunoglobulins; Ischemia; Male; Porphyrias; Raynaud Disease; Skin Diseases | 1970 |
[Various clinico-biochemical comparisons in ischemic stroke (a study of the fibrinogen of fibrinolysis)].
Topics: Cerebrovascular Disorders; Female; Fibrinogen; Fibrinolysis; Humans; Ischemia; Male; Middle Aged | 1968 |
Coagulation changes in regional ischemia.
Topics: Animals; Blood Coagulation; Dogs; Fibrinogen; Hematocrit; Ischemia; Plasminogen; Thromboplastin | 1968 |